Bioisosteres in De Novo Design
暂无分享,去创建一个
[1] K. Stewart,et al. Drug Guru: a computer software program for drug design using medicinal chemistry rules. , 2006, Bioorganic & medicinal chemistry.
[2] Olivier Michielin,et al. SwissBioisostere: a database of molecular replacements for ligand design , 2012, Nucleic Acids Res..
[3] Schmid,et al. "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.
[4] P Ertl,et al. World Wide Web-based system for the calculation of substituent parameters and substituent similarity searches. , 1998, Journal of molecular graphics & modelling.
[5] John P. Overington,et al. ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..
[6] Philip M. Dean,et al. Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design , 1997, J. Comput. Aided Mol. Des..
[7] Ajay,et al. Kinase patent space visualization using chemical replacements. , 2006, Journal of medicinal chemistry.
[8] Andrew G. Leach,et al. Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure. , 2006, Journal of medicinal chemistry.
[9] Peter Ertl,et al. IADE: a system for intelligent automatic design of bioisosteric analogs , 2012, Journal of Computer-Aided Molecular Design.
[10] Gerhard Klebe,et al. Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures , 1994, J. Chem. Inf. Comput. Sci..
[11] J. Thornton,et al. Shape variation in protein binding pockets and their ligands. , 2007, Journal of molecular biology.
[12] Anne Mai Wassermann,et al. Large-scale exploration of bioisosteric replacements on the basis of matched molecular pairs. , 2011, Future medicinal chemistry.
[13] I. Langmuir. ISOMORPHISM, ISOSTERISM AND COVALENCE. , 1919 .
[14] Peter Ertl,et al. Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization , 2010, Molecular informatics.
[15] A Burger,et al. Isosterism and bioisosterism in drug design. , 1991, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.
[16] Philip M Dean,et al. Scaffold hopping in de novo design. Ligand generation in the absence of receptor information. , 2004, Journal of medicinal chemistry.
[17] Peter Ertl,et al. Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups , 2003, J. Chem. Inf. Comput. Sci..
[18] F. Allen. The Cambridge Structural Database: a quarter of a million crystal structures and rising. , 2002, Acta crystallographica. Section B, Structural science.
[19] Toshio Fujita,et al. Concept and features of EMIL, a system for lead evolution of bioactive compounds , 1993 .
[20] Jameed Hussain,et al. Computationally Efficient Algorithm to Identify Matched Molecular Pairs (MMPs) in Large Data Sets , 2010, J. Chem. Inf. Model..
[21] Peter Ertl,et al. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions , 2009, J. Cheminformatics.
[22] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[23] Nathan Brown,et al. Bioisosteres in Medicinal Chemistry: BROWN:BIOISOSTERES MED CH O-BK , 2012 .
[24] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[25] A. Ghose,et al. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.
[26] István Ujváry,et al. Extended Summary: BIOSTER—a database of structurally analogous compounds , 1997 .
[27] Markus Wagener,et al. The Quest for Bioisosteric Replacements , 2006, J. Chem. Inf. Model..
[28] P. N. Craig,et al. Interdependence between physical parameters and selection of substituent groups for correlation studies. , 1971, Journal of medicinal chemistry.
[29] C. Thornber,et al. Isosterism and molecular modification in drug design , 1979 .
[30] Nathan J. Brown. Algorithms for chemoinformatics , 2011 .
[31] Ajay N. Jain,et al. Molecular Shape and Medicinal Chemistry: A Perspective , 2010, Journal of medicinal chemistry.
[32] David Weininger,et al. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..